{"id":589560,"date":"2023-09-02T17:00:00","date_gmt":"2023-09-02T14:00:00","guid":{"rendered":"https:\/\/en.buradabiliyorum.com\/what-to-expect-from-the-emerging-battle-royale-over-drug-prices\/"},"modified":"2023-09-02T17:00:00","modified_gmt":"2023-09-02T14:00:00","slug":"what-to-expect-from-the-emerging-battle-royale-over-drug-prices","status":"publish","type":"post","link":"https:\/\/buradabiliyorum.com\/en\/what-to-expect-from-the-emerging-battle-royale-over-drug-prices\/","title":{"rendered":"#What to expect from the emerging battle royale over drug prices"},"content":{"rendered":"

<\/p>\n

\n

On Aug. 29, the Biden administration announced the\u00a0first 10 drugs whose prices will be negotiated<\/a>\u00a0with pharmaceutical companies this year and next, with lower prices becoming effective in 2026. The stakes are huge for American taxpayers and patients. Medicare enrollees taking the 10 selected drugs paid\u00a0$3.4 billion<\/a>\u00a0in out-of-pocket costs in 2022. These 10 drugs cost Medicare\u00a0$50.5 billion<\/a>\u00a0between June 1, 2022 and May 31, 2023.\u00a0\u00a0<\/p>\n

For President Biden, lowering drug prices is a signature issue, especially approaching the 2024 election. And lower drug prices are hugely popular across party lines. More than 3 in 4 Americans think the costs of prescript<\/a>ion drugs are\u00a0unaffordable<\/a>\u00a0and nearly 1 in 3 say they haven\u2019t taken their medications as prescribed due to cost.\u00a0<\/p>\n